Related Experiment Video
Updated: May 21, 2026

15:19
Effect of Male Accessory Gland Products on Egg Laying in Gastropod Molluscs
Published on: June 22, 2014
[Effects of L-carnitine on ejaculate parameters in males from infertile couples]
Urologiia (Moscow, Russia : 1999)
|June 1, 2012
Summary
L-carnitine supplementation improved sperm quality and antioxidant status in men with idiopathic pathospermia. This antioxidant action of L-carnitine (a transmembrane carrier of long-chain fatty acids) led to increased sperm motility and a 23% pregnancy rate in their partners.
Area of Science:
- Biochemistry
- Reproductive Medicine
- Pharmacology
Context:
- Idiopathic pathospermia significantly impacts male fertility.
- Oxidative stress plays a crucial role in the pathogenesis of idiopathic pathospermia.
- L-carnitine is a vital molecule involved in fatty acid metabolism and cellular energy production.
Purpose:
- To investigate the molecular mechanisms underlying the antioxidant effects of L-carnitine in idiopathic pathospermia.
- To evaluate the efficacy of L-carnitine (Karniton) in improving seminal antioxidant status and sperm parameters in affected males.
- To assess the impact of L-carnitine treatment on pregnancy rates in couples experiencing infertility due to male factor.
Summary:
- L-carnitine demonstrated significant dose-dependent antioxidant activity in vitro.
- In vivo studies showed L-carnitine administration increased the count of motile spermatozoa (Category A) and improved ejaculate's antioxidant capacity.
- Key parameters of ejaculate chemiluminescence (luminal-dependent and Fe2+ induced) showed positive changes, indicating enhanced antioxidant defense.
- Spermatozoa motility and ejaculate antioxidant status were significantly improved following L-carnitine treatment.
Impact:
- L-carnitine treatment resulted in a 23% pregnancy rate among couples where the male partner had idiopathic pathospermia.
- The findings suggest that L-carnitine's therapeutic effect is linked to the normalization of the ejaculate's antioxidant status.
- This study highlights L-carnitine as a potential therapeutic agent for male infertility associated with oxidative stress.
Related Concept Videos
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Spermatogenesis
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Sperm Structure and Semen Composition
During ejaculation, males release around 2-5 milliliters of semen, which is a complex mixture of mature sperm and various fluids produced by accessory glands. The mature sperm cells measure approximately 60 micrometers in length and consist of a head, neck, midpiece, and tail. The head is flattened and tapered, measuring about 4 to 5 micrometers in length. It contains a nucleus with condensed chromosomes and an acrosome, a cap-like structure filled with enzymes essential for penetrating the...
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
